NPI: 1093774473 · WILMINGTON, NC 28401 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,522 | $226K |
| 2019 | 17,320 | $189K |
| 2020 | 21,162 | $268K |
| 2021 | 19,739 | $239K |
| 2022 | 10,370 | $379K |
| 2023 | 8,359 | $441K |
| 2024 | 6,049 | $409K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 44,421 | 3,367 | $1.97M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,933 | 1,581 | $112K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,024 | 562 | $29K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,760 | 1,274 | $19K |
| J1756 | Injection, iron sucrose, 1 mg | 6,004 | 1,574 | $16K |
| A4657 | Syringe, with or without needle, each | 2,830 | 1,784 | $9K |
| 90677 | 21 | 17 | $283.72 | |
| G0008 | Administration of influenza virus vaccine | 73 | 62 | $36.93 |
| G0009 | Administration of pneumococcal vaccine | 13 | 12 | $28.61 |
| 90674 | 36 | 28 | $9.62 | |
| 83550 | 826 | 735 | $0.00 | |
| 82728 | 756 | 678 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,079 | 170 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 414 | 277 | $0.00 |
| 85048 | 1,557 | 1,349 | $0.00 | |
| 85041 | 1,561 | 1,352 | $0.00 | |
| 83970 | 1,332 | 1,147 | $0.00 | |
| 83540 | 828 | 735 | $0.00 | |
| 90670 | 15 | 14 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 38 | 12 | $0.00 |